Amneal Pharmaceuticals (AMRX) Current Leases (2017 - 2026)

Amneal Pharmaceuticals has reported Current Leases for 10 years, with the latest figure at $9.0 million in Q2 2026.

• On a quarterly basis, Current Leases rose 9.94% year-over-year to $9.0 million in Q2 2026; TTM through Jun 2026 was $9.0 million, a 9.94% increase from a year earlier, with the FY2025 full-year figure at $8.7 million, down 8.13% from the prior year.
• Current Leases was $9.0 million for Q2 2026 at Amneal Pharmaceuticals, up from $8.9 million in the prior quarter.
• The five-year high for Current Leases was $10.3 million in Q3 2022, with the low at $8.0 million in Q3 2025.
• Average Current Leases over 5 years is $9.3 million, with a median of $9.3 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Current Leases jumped 49.18% in 2022, then decreased 17.7% in 2025.
• Over 5 years, Current Leases stood at $8.3 million in 2022, then grew by 10.65% to $9.2 million in 2023, then climbed by 2.48% to $9.4 million in 2024, then fell by 8.13% to $8.7 million in 2025, then gained by 4.29% to $9.0 million in 2026.
• The last three Current Leases figures came in at $9.0 million (Q2 2026), $8.9 million (Q1 2026), and $8.7 million (Q4 2025), per Business Quant data.